Cuniloside BCAS# 1187303-40-7 |
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
| Cas No. | 1187303-40-7 | SDF | Download SDF |
| PubChem ID | 91895372 | Appearance | Powder |
| Formula | C26H40O10 | M.Wt | 512.6 |
| Type of Compound | Monoterpenoids | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(4R)-4-(2-hydroxypropan-2-yl)cyclohexene-1-carbonyl]oxyoxan-2-yl]methyl (4R)-4-(2-hydroxypropan-2-yl)cyclohexene-1-carboxylate | ||
| SMILES | CC(C)(C1CCC(=CC1)C(=O)OCC2C(C(C(C(O2)OC(=O)C3=CCC(CC3)C(C)(C)O)O)O)O)O | ||
| Standard InChIKey | JOLLIDAUJSAZHE-SKNUFNKISA-N | ||
| Standard InChI | InChI=1S/C26H40O10/c1-25(2,32)16-9-5-14(6-10-16)22(30)34-13-18-19(27)20(28)21(29)24(35-18)36-23(31)15-7-11-17(12-8-15)26(3,4)33/h5,7,16-21,24,27-29,32-33H,6,8-13H2,1-4H3/t16-,17-,18+,19+,20-,21+,24-/m0/s1 | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Cuniloside B shows anti-leishmanial activity. |
| Targets | Antifection |
Cuniloside B Dilution Calculator
Cuniloside B Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.9508 mL | 9.7542 mL | 19.5084 mL | 39.0168 mL | 48.771 mL |
| 5 mM | 0.3902 mL | 1.9508 mL | 3.9017 mL | 7.8034 mL | 9.7542 mL |
| 10 mM | 0.1951 mL | 0.9754 mL | 1.9508 mL | 3.9017 mL | 4.8771 mL |
| 50 mM | 0.039 mL | 0.1951 mL | 0.3902 mL | 0.7803 mL | 0.9754 mL |
| 100 mM | 0.0195 mL | 0.0975 mL | 0.1951 mL | 0.3902 mL | 0.4877 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Resminostat hydrochloride
Catalog No.:BCC1888
CAS No.:1187075-34-8
- H-Cys(Me)-OH
Catalog No.:BCC2908
CAS No.:1187-84-4
- 11-Hydroxycodaphniphylline
Catalog No.:BCN6061
CAS No.:1186496-68-3
- Evacetrapib (LY2484595)
Catalog No.:BCC2329
CAS No.:1186486-62-3
- TMN 355
Catalog No.:BCC6121
CAS No.:1186372-20-2
- Epivogeloside
Catalog No.:BCN6060
CAS No.:118627-52-4
- 4SC-202
Catalog No.:BCC5359
CAS No.:1186222-89-8
- ALW-II-41-27
Catalog No.:BCC1350
CAS No.:1186206-79-0
- NPE-caged-proton
Catalog No.:BCC7698
CAS No.:1186195-63-0
- MTEP hydrochloride
Catalog No.:BCC1780
CAS No.:1186195-60-7
- Tocrifluor T1117
Catalog No.:BCC7401
CAS No.:1186195-59-4
- BU 226 hydrochloride
Catalog No.:BCC6936
CAS No.:1186195-56-1
- Trametinib DMSO solvate
Catalog No.:BCC2013
CAS No.:1187431-43-1
- PF 184
Catalog No.:BCC6130
CAS No.:1187460-81-6
- Baricitinib (LY3009104, INCB028050)
Catalog No.:BCC2195
CAS No.:1187594-09-7
- Baricitinib phosphate
Catalog No.:BCC1401
CAS No.:1187595-84-1
- Carabrolactone A
Catalog No.:BCN6063
CAS No.:1187925-30-9
- Carabrolactone B
Catalog No.:BCN6064
CAS No.:1187925-31-0
- Diosbulbin I
Catalog No.:BCN6065
CAS No.:1187951-05-8
- Diosbulbin J
Catalog No.:BCN6066
CAS No.:1187951-06-9
- Ac-Leu-OH
Catalog No.:BCC2967
CAS No.:1188-21-2
- ent-14,16-Epoxy-8-pimarene-3,15-diol
Catalog No.:BCN6067
CAS No.:1188281-98-2
- 7-Hydroxydarutigenol
Catalog No.:BCN6068
CAS No.:1188281-99-3
- 9-Hydroxydarutigenol
Catalog No.:BCN6069
CAS No.:1188282-00-9
Terpenoidal constituents of Eucalyptus loxophleba ssp. lissophloia.[Pubmed:22468852]
Pharm Biol. 2012 Jul;50(7):823-7.
CONTEXT: Eucalyptus has been a source of a number of biologically active compounds. The anti-leishmanial activity of terpenoids from Eucalyptus loxophleba (Benth.) ssp. lissophloia (Myrtaceae) has not yet been investigated. OBJECTIVE: Isolation of the terpenoidal constituents for evaluation of in vitro anti-leishmanial activity against the Leishmania donovani (Dd8 strain) promastigotes. MATERIALS AND METHODS: The chloroform-methanol (8:2) extract of dried leaves of Eucalyptus loxophleba was used to isolate terpenoidal constituents employing solvent partitioning, column chromatography and preparative high performance liquid chromatography and characterized from spectral data. The anti-leishmanial activity of the isolated compounds was tested in vitro using an Alamar blue assay against a culture of L. donovani (Dd8 strain) promastigotes. RESULTS: Two new naturally occurring triterpenes, named loxanic acid and 3-acetyl loxanic acid together with four known ursane triterpenoids and one bis-monoterpene glycoside, Cuniloside B isolated from the leaves showed anti-leishmanial activity (IC(50) 133 to 235 muM) against the promastigotes of the tested strain. CONCLUSION: The terpenes isolated from the leaves of E. loxophleba showed moderate anti-leishmanial activity.
Synthesis of the monoterpenoid esters cypellocarpin C and cuniloside B and evidence for their widespread occurrence in Eucalyptus.[Pubmed:20708173]
Carbohydr Res. 2010 Sep 23;345(14):2079-84.
Short syntheses of Cuniloside B and cypellocarpin C, (+)-(R)-oleuropeic acid-containing carbohydrates, are reported. Also disclosed are syntheses of the noreugenin glycosides, undulatoside A and corymbosins K(1) and K(2). Leaf extracts of 28 diverse eucalypts revealed Cuniloside B to be present in all, and cypellocarpin C to be present in most, of the species examined. The widespread occurrence of these carbohydrate monoterpenoid esters supports their roles in essential oil biosynthesis or mobilization from sites of synthesis to secretory cavity lumena.
